Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

261 trials with published results (23%)

Research Maturity

782 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

7.5%

86 terminated out of 1147 trials

Success Rate

90.1%

+3.5% vs benchmark

Late-Stage Pipeline

28%

317 trials in Phase 3/4

Results Transparency

33%

261 of 782 completed with results

Key Signals

261 with results90% success86 terminated

Data Visualizations

Phase Distribution

901Total
Not Applicable (440)
Early P 1 (5)
P 1 (55)
P 2 (84)
P 3 (150)
P 4 (167)

Trial Status

Completed782
Unknown116
Recruiting86
Terminated86
Withdrawn31
Active Not Recruiting22

Trial Success Rate

90.1%

Benchmark: 86.5%

Based on 782 completed trials

Clinical Trials (1147)

Showing 20 of 20 trials
NCT07404943Not ApplicableCompletedPrimary

The Effect of Telenursing on Functionality and Treatment Adherence in Bipolar Disorder

NCT05828056RecruitingPrimary

Prediction on the Recurrence of Manic and Depressive Episodes in Bipolar Disorder

NCT06229210Phase 3Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

NCT06365021Not ApplicableCompletedPrimary

ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder

NCT07556861Not ApplicableNot Yet RecruitingPrimary

Senyo Health App - Comorbid Alcohol Use Disorder Treatment in Individuals With Bipolar Disorder Using a Telehealth Collaborative Care Platform

NCT00024635Recruiting

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

NCT07411222Recruiting

Emotional Eating, Sleep Quality, Mental State and Metabolic Syndrome

NCT07534475Not ApplicableRecruiting

Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT

NCT02719392Phase 4WithdrawnPrimary

A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression

NCT02481245Phase 2CompletedPrimary

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

NCT00001174Active Not RecruitingPrimary

Evaluation of the Genetics of Bipolar Disorder

NCT05064319Phase 2RecruitingPrimary

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

NCT07286175Phase 2RecruitingPrimary

A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

NCT03336918CompletedPrimary

Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder

NCT06274567Not ApplicableRecruitingPrimary

Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder

NCT06560749Not ApplicableRecruitingPrimary

Physical Exercise for Cognitive Rehabilitation of Patients With Bipolar Affective Disorder

NCT04696471Not ApplicableCompletedPrimary

Effects of Theta Burst Stimulation on the Brain, Behavior, and Clinical Symptoms in Adults With Bipolar Disorder

NCT07692984Recruiting

The Effect of Comorbid Alcohol/Substance Use

NCT04454073Active Not RecruitingPrimary

Investigation of Factors Associated With Preserved Cognitive Function in Bipolar Disorder

NCT05877716Not ApplicableActive Not Recruiting

EPI-MINN: Targeting Cognition and Motivation - National

Scroll to load more

Research Network

Activity Timeline